-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharmaceuticals Director David H. Deming Acquires $9,822.60 in Common Shares

PUBT·11/16/2026 15:31:00
Listen to the news
Phio Pharmaceuticals Director David H. Deming Acquires $9,822.60 in Common Shares
  • Phio Pharmaceuticals director David H. Deming purchased 9,000 common shares at $0.8136 each.
  • A second purchase added 3,000 common shares at $0.8334 each.
  • His directly held beneficial ownership rose to 61,800 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008786), on November 16, 2026, and is solely responsible for the information contained therein.